Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBDIX vs SHPAX overlap: 19% of top holdings shared

Bottom line

How much do FBDIX and SHPAX overlap?

19% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 16.9% of FBDIX's assets and 18.4% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.

FBDIX holds far more positions (126 vs 29), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FBDIXSHPAX
Weight overlap (top 25)19%
Shared holdings5
Weight in shared holdings16.9%18.4%
Total positions12629
Expense ratio1.01%3%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FBDIX and SHPAX have in common

Holding% of FBDIX% of SHPAXOverlap
Amgen, Inc.4.39%5.04%4.39%
Gilead Sciences, Inc.3.86%3.94%3.86%
Regeneron Pharmaceuticals, Inc.3.77%3.93%3.77%
Vertex Pharmaceuticals, Inc.3.54%3.36%3.36%
Eli Lilly & Co.1.31%2.11%1.31%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Argenx SE — 3.62%
  3. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  4. Revolution Medicines, Inc. — 3.01%
  5. Guardant Health, Inc. — 2.76%
  6. Ascendis Pharma A/S — 2.56%
  7. Dianthus Therapeutics, Inc. — 2.32%
  8. Insmed, Inc. — 1.99%
  9. Mirum Pharmaceuticals, Inc. — 1.98%
  10. Praxis Precision Medicines, Inc. — 1.91%
  11. Spyre Therapeutics, Inc. — 1.87%
  12. Oruka Therapeutics, Inc. — 1.86%
  13. Neurocrine Biosciences, Inc. — 1.82%
  14. Bridgebio Pharma, Inc. — 1.67%
  15. PTC Therapeutics, Inc. — 1.65%

Only in SHPAX

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Mckesson Corp — 4.90%
  5. Lantheus Holdings Inc — 4.64%
  6. Exelixis Inc — 4.55%
  7. Novartis Ag — 4.50%
  8. Cencora Inc — 4.33%
  9. Johnson & Johnson — 3.91%
  10. National Healthcare Corp — 3.72%
  11. Merck & Company Inc — 3.63%
  12. Cigna Group (the) — 3.63%
  13. Medpace Holdings Inc — 3.37%
  14. Intuitive Surgical Inc — 3.14%
  15. Bristol-myers Squibb Company — 3.07%

Asset mix

Asset typeFBDIXSHPAX
Stocks97.0%99.0%
Cash & short-term funds4.6%1.6%
Preferred stock1.0%—
Other0.6%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFBDIXSHPAX
US82.0%86.1%
IE6.7%8.4%
CH1.2%4.5%
NL4.5%—
DK2.6%1.6%
FR1.7%—
GB1.5%—
CA1.3%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FBDIX and SHPAX overlap?
About 19% by weight. 5 securities appear in both funds' top 25 holdings; they make up 16.9% of FBDIX's assets and 18.4% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do FBDIX and SHPAX have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., Eli Lilly & Co..
Should I own both FBDIX and SHPAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, FBDIX or SHPAX?
FBDIX is broader, with 126 positions versus 29 for SHPAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.